Skip to content

GDK FARMA: what changed

What changed

GDK FARMA

BE 0899.813.966
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
-€339,047
31-03-2025 · €2,044-€341,091
Equity
€3.0m
31-03-2025 · €3.4m-€339,047
Cash
€1,844
31-03-2025 · €228,345-€226,501
Balance sheet total
€3.1m
31-03-2025 · €3.4m-€374,513

Largest movements

31-03-2025 to 31-12-2025
Assets
  • Receivables after one year -€561,198

    no longer reported in 2025 (was €561,198)

  • Financial fixed assets +€481,305

    up €481,305 (+22.1%), from €2.2m to €2.7m

  • Cash -€226,501

    down €226,501 (-99.2%), from €228,345 to €1,844

    mainly Investment in fixed assets (net) (-€481,305) and Net result for the year (-€339,047)

  • Receivables within one year -€67,962

    down €67,962 (-14.1%), from €481,890 to €413,928

    of which Other amounts receivable: -€57,002

Equity and liabilities
  • Contributions -€600,000

    down €600,000 (-15.1%), from €4.0m to €3.4m

  • Profit (loss) carried forward +€260,953

    up €260,953 (+42.3%), from -€617,091 to -€356,139

  • Trade debts -€35,465

    down €35,465 (-42.3%), from €83,901 to €48,436

Income statement
  • Gross operating margin -€1,887

    down €1,887 (-17.1%), from €11,007 to €9,120

  • Other operating charges -€1,211

    down €1,211 (-41.9%), from €2,888 to €1,677

  • Financial charges -€968

    down €968 (-13.1%), from €7,366 to €6,398

    of which Financial charges: -€7,268

  • Financial income +€203

    up €203 (+15.7%), from €1,290 to €1,493

Change in the result, 31-03-2025 to 31-12-2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 31-03-2025 €2,044
Gross operating margin -€1,887
Other operating charges +€1,211
Other operating items -€341,586
Financial income +€203
Financial charges +€968
Result 31-12-2025 -€339,047
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 31-03-2025 to 31-12-2025

The bridge is derived from the 31-03-2025 and 31-12-2025 balance sheets and the 31-12-2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€254,805
Investment -€481,305
Financing €0
Cash 31-03-2025 €228,345
Net result for the year -€339,047
Receivables after one year +€561,198
Receivables within one year +€67,962
Deferred charges and accrued income +€158
Trade debts -€35,465
Investment in fixed assets (net) -€481,305
Cash 31-12-2025 €1,844
brings cash intakes cash out
Every line side by side 33 lines
Line Code 31-03-2025 31-12-2025 Change %
Total assets 20/58 €3,448,559 €3,074,047 -€374,513 -10.9%
Fixed assets 21/28 €2,176,969 €2,658,275 +€481,305 +22.1%
Financial fixed assets 28 €2,176,969 €2,658,275 +€481,305 +22.1%
Current assets 29/58 €1,271,590 €415,772 -€855,818 -67.3%
Amounts receivable after more than one year 29 €561,198 - -€561,198
Other amounts receivable 291 €561,198 - -€561,198
Amounts receivable within one year 40/41 €481,890 €413,928 -€67,962 -14.1%
Trade receivables 40 €48,597 €37,637 -€10,960 -22.6%
Other amounts receivable 41 €433,293 €376,291 -€57,002 -13.2%
Cash at bank and in hand 54/58 €228,345 €1,844 -€226,501 -99.2%
Deferred charges and accrued income 490/1 €158 - -€158
Total equity and liabilities 10/49 €3,448,559 €3,074,047 -€374,513 -10.9%
Equity 10/15 €3,364,658 €3,025,611 -€339,047 -10.1%
Contributions 10/11 €3,981,750 €3,381,750 -€600,000 -15.1%
Capital 10 €3,981,750 €3,381,750 -€600,000 -15.1%
Issued capital 100 €3,981,750 €3,381,750 -€600,000 -15.1%
Profit (loss) carried forward 14 -€617,091 -€356,139 +€260,953 +42.3%
Amounts payable 17/49 €83,901 €48,436 -€35,465 -42.3%
Amounts payable within one year 42/48 €83,901 €48,436 -€35,465 -42.3%
Trade debts 44 €83,901 €48,436 -€35,465 -42.3%
Suppliers 440/4 €83,901 €48,436 -€35,465 -42.3%
Other operating charges 640/8 €2,888 €1,677 -€1,211 -41.9%
Non-recurring operating charges 66A - €341,586 +€341,586
Gross operating margin 9900 €11,007 €9,120 -€1,887 -17.1%
Operating profit (loss) 9901 €8,119 -€334,142 -€342,262
Financial income 75/76B €1,290 €1,493 +€203 +15.7%
Recurring financial income 75 €1,290 €1,493 +€203 +15.7%
Financial charges 65/66B €7,366 €6,398 -€968 -13.1%
Recurring financial charges 65 €7,366 €98 -€7,268 -98.7%
Non-recurring financial charges 66B - €6,300 +€6,300
Profit (loss) for the period before taxes 9903 €2,044 -€339,047 -€341,091
Profit (loss) for the period 9904 €2,044 -€339,047 -€341,091
Profit (loss) for the period to be appropriated 9905 €2,044 -€339,047 -€341,091
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 March 2025 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.